摘要
目的探究益肾壮骨合剂联合钙尔奇D对糖尿病合并骨质疏松症的临床治疗效果。方法选取在该院接受治疗的90例糖尿病合并骨质疏松症患者,将所有患者随机分为对照组和观察组两组,在常规治疗的基础上,对照组患者仅接受钙尔奇D进行治疗,观察组患者接受益肾壮骨合剂联合钙尔奇D进行治疗,对两组患者治疗后的临床效果、血糖水平以及骨密度等进行观察分析。结果治疗后,观察组的治疗有效率明显高于对照组(P<0.05);观察组患者骨密度治疗后改善程度显著高于对照组(P<0.05),同时观察组患者的血糖、血磷、血钙以及骨碱性磷酸酶水平的改善程度明显优于对照组(P<0.05)。结论对糖尿病合并骨质疏松症患者在常规降糖的基础上进行益肾壮骨合剂联合钙尔奇D的治疗能够显著改善患者的骨密度以及血糖水平,值得在临床广泛推广。
Objective To study the effect of Yishenzhuanggu mixture combined with Cahrate D in treatment of diabetes and osteoporosis. Methods 90 cases of patients with diabetes and osteoporosis treated in our hospital were selected and random- ly divided into two groups, the control group adopted the Caltrate D treatment, while the observation group adopted the Yishenzhuanggu mixture combined with Cahrate D treatment, and the clinical effect after treatment, blood sugar level and bone density were observed and analyzed. Results After treatment, the treatment effective rate in the observation group was obvious!y^higher than that in the control group(P〈0.05), the bone density improvement degree after treatment in the obser- vation group was obviously higher than that in the control group (P〈0.05), at the same time, the blood sugar, serium inor- ganic phosphorus, blood calcium and bone alkaline phosphatase level improvement degrees in the observation group was obviously better than those in the control group (P〈O.05). Conclusion The Yishenzhuanggu mixture combined with Cahrate D in treatment of diabetes and osteoporosis on the basis of the routine blood sugar decreasing can obviously improve the bone density and blood sugar level of patients, which is worth wide promotion in clinic.
出处
《糖尿病新世界》
2017年第1期9-10,共2页
Diabetes New World Magazine